Cargando…

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide

Current anti-hepatitis B virus (HBV) agents including interferons and nucleos(t)ide analogs efficiently suppress HBV infection. However, as it is difficult to eliminate HBV from chronically infected liver, alternative anti-HBV agents targeting a new molecule are urgently needed. In this study, we ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Manabu, Futamura, Yushi, Tsukuda, Senko, Kondoh, Yasumitsu, Sekine, Tomomi, Hirano, Hiroyuki, Fukano, Kento, Ohashi, Hirofumi, Saso, Wakana, Morishita, Ryo, Matsunaga, Satoko, Kawai, Fumihiro, Ryo, Akihide, Park, Sam-Yong, Suzuki, Ryosuke, Aizaki, Hideki, Ohtani, Naoko, Sureau, Camille, Wakita, Takaji, Osada, Hiroyuki, Watashi, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807303/ https://www.ncbi.nlm.nih.gov/pubmed/29426822 http://dx.doi.org/10.1038/s41598-018-20987-w

Ejemplares similares

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019)

Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide
por: Miyakawa, Kei, et al.
Publicado: (2018)

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
por: Watashi, Koichi, et al.
Publicado: (2014)

Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide
por: Okuyama-Dobashi, Kaori, et al.
Publicado: (2015)

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
por: Shimura, Satomi, et al.
Publicado: (2017)

Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
por: Iwamoto, Masashi, et al.
Publicado: (2017)

Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival
por: Kawamura, Tatsuro, et al.
Publicado: (2016)

Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022)

Signal Peptidase Complex Subunit 1 Participates in the Assembly of Hepatitis C Virus through an Interaction with E2 and NS2
por: Suzuki, Ryosuke, et al.
Publicado: (2013)

Molecular dissection of HBV evasion from restriction factor tetherin: A new perspective for antiviral cell therapy
por: Miyakawa, Kei, et al.
Publicado: (2015)

Na(+)‐taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
por: Slijepcevic, Davor, et al.
Publicado: (2018)

Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide
por: Witzigmann, Dominik, et al.
Publicado: (2019)

Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients
por: Dong, Chen, et al.
Publicado: (2019)

Hepatic Expression of the Na(+)-Taurocholate Cotransporting Polypeptide Is Independent from Genetic Variation
por: Tremmel, Roman, et al.
Publicado: (2022)

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core Protein
por: Nishi, Mayuko, et al.
Publicado: (2020)

Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency
por: Deng, Mei, et al.
Publicado: (2016)

Blocking Sodium‐Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice
por: Roscam Abbing, Reinout L.P., et al.
Publicado: (2019)

Effect of mTOR inhibitors on sodium taurocholate cotransporting polypeptide (NTCP) function in vitro
por: Saran, Chitra, et al.
Publicado: (2023)

MCPIP1 reduces HBV-RNA by targeting its epsilon structure
por: Li, Yingfang, et al.
Publicado: (2020)

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
por: Yan, Huan, et al.
Publicado: (2012)

Age‐dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers
por: Sargiacomo, Camillo, et al.
Publicado: (2018)

Calnexin Depletion by Endoplasmic Reticulum Stress During Cholestasis Inhibits the Na(+)‐Taurocholate Cotransporting Polypeptide
por: Robin, Marion J.D., et al.
Publicado: (2018)

Monozygotic Twins Suffering From Sodium Taurocholate Cotransporting Polypeptide Deficiency: A Case Report
por: Tan, Hui-Jun, et al.
Publicado: (2018)

Structural Plasticity Is a Feature of Rheostat Positions in the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP)
por: Ruggiero, Melissa J., et al.
Publicado: (2022)

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins
por: Miyakawa, Kei, et al.
Publicado: (2022)

Correction: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
por: Yan, Huan, et al.
Publicado: (2014)

Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques
por: Burwitz, Benjamin J., et al.
Publicado: (2017)

A clinically relevant polymorphism in the Na(+)/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position
por: Ruggiero, Melissa J., et al.
Publicado: (2020)

Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review
por: Zou, Ting-Ting, et al.
Publicado: (2021)

Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression
por: Tasaka-Fujita, Megumi, et al.
Publicado: (2015)

Corrigendum: Amino Acid Polymorphisms in Hepatitis C Virus Core Affect Infectious Virus Production and Major Histocompatibility Complex Class I Molecule Expression
por: Tasaka-Fujita, Megumi, et al.
Publicado: (2015)

Identification of a small‐molecule ligand of β‐arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells
por: Suvarna, Kruthi, et al.
Publicado: (2018)

Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma
por: Iwanami, Shoya, et al.
Publicado: (2020)

Inhibition of mitochondrial complex I by the novel compound FSL0260 enhances high salinity-stress tolerance in Arabidopsis thaliana
por: Sako, Kaori, et al.
Publicado: (2020)

Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B
por: Zhao, Kaitao, et al.
Publicado: (2018)

The Lipid Raft Component Stomatin Interacts with the Na(+) Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake
por: Appelman, Monique D., et al.
Publicado: (2020)

Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B Virus
por: Matsunaga, Satoko, et al.
Publicado: (2020)

NTCP and Beyond: Opening the Door to Unveil Hepatitis B Virus Entry
por: Watashi, Koichi, et al.
Publicado: (2014)

High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon
por: Matsuda, Mami, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k6l2gqvrv12v581jb2eqbefb7p